Chest
-
Comorbidities of OSA PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Type 2 diabetes mellitus (DM) and obstructive sleep apnea (OSA) share clinical outcomes being in this way a major public health concern. OSA may be under-recognised comorbidity of DM, so recent reports have indicated that the majority of patients with type 2 diabetes also have obstructive sleep apnea syndrome (OSA). The aim of the study was to evaluate the presence of diabetes mellitus between patients with obstructive sleep apnea syndrome. ⋯ The following authors have nothing to disclose: Doina Adina Todea, Paraschiva Postolache, Andreea Codruta Coman, Loredana Elena RoscaNo Product/Research Disclosure Information.
-
Critical CareSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 04:15 PM - 05:15 PMPURPOSE: Tuberculosis remains an important health problem. The aim of this study was to evaluate the clinical characteristics, prognoses and predictors of mortality of patients with pulmonary tuberculosis (TB) with acute respiratory failure (ARF). We conducted a retrospective observational study ⋯ The following authors have nothing to disclose: Filiz Kosar, Pelin Uysal, Levent Dalar, Emel Eryüksel, Aybuke Kekecoglu, Turkay AkbasNo Product/Research Disclosure Information.
-
Pulmonary and Sleep MedicineSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: Routine manometry has been advocated to prevent complications during therapeutic thoracentesis, but has not convincingly been shown to prevent pneumothorax ex vacuo or re-expansion pulmonary edema. As chest pain is correlated with negative pleural pressures, we aimed to determine whether the use of manometry could be associated with less pain during therapeutic thoracentesis. ⋯ The following authors have nothing to disclose: Jasleen Pannu, Zachary DePew, John Mullon, Craig Daniels, Clinton Hagen, Fabien MaldonadoNo Product/Research Disclosure Information.
-
Late Breaking AbstractsSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: Bevacizumab is an anti-angiogenic agent used in many advanced solid tumours, including non-squamous NSCLC. In contrast to clinical studies, that all patients are fit, we retrospectively try to evaluate safety of Bv in superannuated population ⋯ The following authors have nothing to disclose: Andriani Charpidou, Dimitrios Vassos, Sotirios Tsimpoukis, Panagiotis Demertzis, Ioannis Gkiozos, Kostas SyrigosNo Product/Research Disclosure Information.
-
Late Breaking AbstractsSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: Venous thromboembolism (VTE) remained common following surgical resection of esophageal cancer. In this prospective randomized controlled trial (NCT01267305), we aim to compare the safety and efficacy between two anticoagulants applied in the prophylaxis of VTE following esophagectomy. ⋯ The following authors have nothing to disclose: Yaxing Shen, Ming Zhong, Lijie TanNo Product/Research Disclosure Information.